Benefit-Risk Assessment in Pharmaceutical Research and Development

Discover the essential guide to benefit-risk assessment in pharmaceutical research and development with Benefit-Risk Assessment in Pharmaceutical Research and Development by Andreas Sashegyi. Published by Taylor & Francis Ltd in 2020, this insightful paperback spans 220 pages and compiles the knowledge of 15 experts from both academia and industry.

This book provides a comprehensive overview of the critical stages of benefit-risk assessment, covering everything from early clinical development to late-stage development, regulatory review, and post-launch evaluation. Whether you are a professional in the pharmaceutical sector, a researcher, or a student, this resource offers valuable insights into the methodologies and considerations necessary for effective decision-making in drug development. Enhance your understanding of therapeutic assessments and navigate the complexities of pharmaceutical R&D with this indispensable guide.